Weekly Docetaxel and Fixed-Dose Rate Gemcitabine Combination Chemotherapy
Clinical trial NCT00807261 · UNKNOWN
Trial details
- NCT number
- NCT00807261
- Sponsor
- Asan Medical Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-01
- Primary completion
- 2010-09-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.